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Abstract
SIRT1 is a NAD-dependent deacetylase that regulates a variety of pathways including the stress protection pathway. SIRT1
deacetylates a number of protein substrates, including histones, FOXOs, PGC-1a, and p53, leading to cellular protection. We
identified a functional interaction between cJUN N-terminal kinase (JNK1) and SIRT1 by coimmunoprecipitation of
endogenous proteins. The interaction between JNK1 and SIRT1 was identified under conditions of oxidative stress and
required activation of JNK1 via phosphorylation. Modulation of SIRT1 activity or protein levels using nicotinamide or RNAi
did not modify JNK1 activity as measured by its ability to phosphorylate cJUN. In contrast, human SIRT1 was phosphorylated
by JNK1 on three sites: Ser27, Ser47, and Thr530 and this phosphorylation of SIRT1 increased its nuclear localization and
enzymatic activity. Surprisingly, JNK1 phosphorylation of SIRT1 showed substrate specificity resulting in deacetylation of
histone H3, but not p53. These findings identify a mechanism for regulation of SIRT1 enzymatic activity in response to
oxidative stress and shed new light on its role in the stress protection pathway.
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Introduction
Sirtuins are NAD
+-dependent deacetylases (or ADP-ribosyl-
transferases) that remove acetyl groups from (or add ADP-ribose
to) protein substrates, thereby regulating the biological function of
their targets [1]. By catalyzing these reactions, sirtuins increase
tissue and organism survival in a diversity of species, ranging from
yeast to mammals [2,3,4]. The prototypical sirtuin, yeast Sir2p, is
a NAD-dependent deacetylase that removes acetyl groups from
histones to regulate chromatin structure [5]. In humans, the Sir2p
homolog SIRT1 deacetylates transcription factors such as p53,
FOXOs, and nuclear factor Kappa B (NFkB) mediating stress
resistance, apoptosis, and inflammatory responses among other
pathways[6]. Evidence from uni- and multicellular organisms
indicates that SIRT1 has evolved to mediate signaling initiated by
stressors, such as nutrient deprivation, to produce adaptation to
enhance organism survival [7]. Consistent with this concept, extra
copies of sirtuin genes increase survival in model organisms,
including yeast, flies, and worms [2,3,4].
Recent studies have shown that SIRT1 can also protect
organisms from the effects of oxidative stress [8,9]. Reactive
oxygen species (ROS) can damage a number of essential cellular
components including lipid membranes, DNA, and proteins. The
cellular response to an increase in ROS often involves the
activation of numerous intracellular signaling cascades such as the
family of mitogen-activated protein kinases (MAPKs) [10]. One
family member of the MAPKs, c-Jun N-terminal kinase 1 (JNK1),
plays a key role in signal transduction via growth factors, cytokines
and cellular stresses such as heat shock, UV radiation and ROS.
JNK1 phosphorylates components of the activator protein
transcription factor complex such as c-Jun resulting in a change
(e.g. hypertrophy or apoptosis) in cellular fate [11,12,13].
At present, the cellular machinery involved in the signal
transduction from ROS to SIRT1 induced protection is unclear.
Given the roles of JNK1 and SIRT1 in stress protection pathways,
we tested for functional interactions between these proteins. In the
present study, we report post-translational modification of SIRT1
as a result of JNK1 activation. JNK1 directly phosphorylates
SIRT1 on three specific residues, concentrating it in the nucleus
and resulting in selective activation of SIRT1, as measured by
deacetylation of histone H3 (but not p53).
Results
Characterization of SIRT1:JNK1 Interaction
SIRT1 has been implicated in a variety of cellular processes;
however mechanisms regulating SIRT1 activity in cells are largely
unknown. Given our interest in understanding SIRT1 regulation in the
context of oxidative stress, we tested for a functional relationship
between SIRT1 and JNK1 in a cellular system. To examine a potential
interaction between SIRT1 and JNK1, co-immunoprecipitation
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phosphorylated JNK1 (pJNK1) were immunoprecipitated and associ-
ated proteins were identified by Western blotting. An interaction
between SIRT1 and JNK1 was observed only when cells were treated
with the known JNK1 activators anisomycin or H2O2 (Fig. 1A).
Anisomycin and H2O2treatment led to phosphorylation of JNK1, as
expected. When either JNK1 or pJNK1 were immunoprecipitated
following treatment of HEK293T cells with or without anisomycin,
SIRT1 only co-immunoprecipitated with the antibody against pJNK1,
further indicating SIRT1 interacts with phosphorylated- but not
unphosphorylated JNK1 (Fig. 1B). A similar result was obtained using
a different cell line (C2C12) where treatment with anisomycin or H2O2
resulted in interaction between SIRT1 and pJNK1 (Fig. 1C).
To determine the mechanism of regulation of SIRT1 by JNK1,
cellular localization of SIRT1 was examined after treatment with
H2O2 in the presence or absence of JNKi, a cell permeable
inhibitor of JNK1. Immunohistochemistry demonstrated SIRT1
was localized both in cytoplasmic and nuclear compartments in
control C2C12 cells (Fig. 2A). Treatment with H2O2 increased
nuclear localization of SIRT1 (Fig. 2B), and inhibition of JNK1 by
JNKi resulted in decreased nuclear localization of SIRT1 in the
presence of H2O2 (Fig. 2D). JNKi alone did not show any effect
(Fig. 2C). JNK1 was primarily localized to the nucleus. These
findings demonstrate that JNK1 may play a role in the function
and localization of SIRT1.
SIRT1 Does Not Affect JNK1 Activity
Next, we determined that the interaction between SIRT1 and
JNK1 has no effect on JNK1 activity. HEK293T cells were treated
with anisomycin and SIRT1 was inhibited acutely (nicotinamide/
Sirtinol) or chronically (knockdown by siRNA). Acute inhibition of
SIRT1 activity did not significantly change the phosphorylation or
activity of JNK1 by anisomycin treatment (Fig. 3A, 3B). In
addition, chronic inhibition via knockdown of SIRT1 did not
significantly change the phosphorylation state or activity of JNK1
in HEK293T cells treated with or without anisomycin (Fig. 3C,
3D). Thus, SIRT1 does not significantly affect JNK1 phosphor-
ylation or activity under these conditions.
JNK1 Directly Phosphorylates SIRT1
To determine if JNK1 phosphorylated SIRT1 directly, we
measured radioactive phosphate incorporation into SIRT1 by in
vitro kinase assaysand autoradiographywith JNK1,ora non-specific
kinase, namely glycogen synthase kinase-3b (GSK3b). Human
SIRT1 contains two previously identified phosphorylation sites
(Ser27 and Ser47) of unknown function. Recombinant purified
hSIRT1 (FL hSIRT1) protein was phosphorylated by JNK1 but not
GSK3b (Fig. 4B). These findings were corroborated using SIRT1
immunoprecipitated from HEK293 cells treated with anisomycin
(data not shown). Interestingly, a truncated hSIRT1 protein
construct (SIRT1 a.a.170–701) not containing the Ser27 and
Ser47 phosphorylationsites, was alsophosphorylated by JNK1, (but
notGSK3b)indicatinga potentialnovel site.Therefore,wemapped
JNK1 phosphorylation sites on SIRT1 using mass spectrometry
(Fig. 5). Three phosphorylation sites were identified; the previously
known Ser27 and Ser47 sites and a novel site, Thr530. JNK2 and
JNK3 also phosphorylated FL hSIRT1 (data not shown), albeit to a
lesser degree, (relative to JNK protein levels) indicating that
phosphorylation of SIRT1 by JNK proteins may represent a
general mechanism for SIRT1 activity regulation.
To further assess the specificity of JNK1 phosphorylation of
SIRT1, we used recombinant mouse SIRT1 (mSIRT1). In
contrast to hSIRT1, mSIRT1 does not contain the Ser27 and
Thr530 phosphorylation sites (Fig. 4C). An N-terminal fragment
of mSIRT1 (N-term) was effectively phosphorylated by recombi-
nant JNK1 or by JNK1 immunoprecipitated from anisomycin-
treated HEK293T cells (Fig. 3D), whereas a C-terminal fragment
of mSIRT1 was not (Fig. 4D). These results demonstrate that
JNK1 is capable of phosphorylating both human and mouse
SIRT1 protein, but differentially based on their amino acid
sequences. Given that both the mouse and human SIRT1 proteins
contain many potential JNK1 phosphorylation sites (based on the
S/T-P JNK1 phosphorylation motif), the results also suggest a
degree of phosphorylation specificity.
Mutation of JNK1 Phosphorylation Sites on SIRT1
Abrogates Functional Response
To probe the function of SIRT1 phosphorylation, a mutant
hSIRT1 (Mt-SIRT1) protein was generated by site-directed muta-
genesis of Ser27, Ser47 and Thr530 to alanine residues. Whereas
recombinant FL hSIRT1 was effectively phosphorylated by JNK1 in
vitro, phosphorylation of Mt-SIRT1 by JNK1 was dramatically
reduced (Fig. 6A). To assess the functional relevance of these
phosphorylation sites, WT or Mt-SIRT1 were expressed in
Figure 1. SIRT1 and JNK1 interact. A, Coimmunoprecipitation of SIRT1 with total JNK1 and phospho-JNK1 after treatment with anisomycin or
H2O2. Anisomycin and H2O2 cause phosphorylation of JNK1 and interaction with SIRT1. B, Coimmunoprecipitation of SIRT1 with either total JNK1 or
phospho-JNK1 from HEK293 cell lysates. SIRT1 immunoprecipitated specifically with phospho-JNK1 in response to anisomycin. C, Coimmunopre-
cipitation of SIRT1 with either total JNK1 plus phospho-JNK1 or phospho-JNK1 from C2C12 cell lysates. SIRT1 immunoprecipitated with phospho-
JNK1 in response to anisomycin or H2O2.
doi:10.1371/journal.pone.0008414.g001
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the acetylation status of two SIRT1 targets. As expected, cells
transfected with WT-hSIRT1 show markedly decreased acetylation of
the SIRT1 substrates histone H3 and p53 (Fig. 6B and 6C). Cells
transfected with Mt-SIRT1 had differential effects, depending on the
SIRT1 protein substrate measured. There was not a significant
difference in p53 acetylation in cells transfected with either WT-
hSIRT or Mt-SIRT1 when treated with H2O2 (Fig. 6C), indicating
no dependence on SIRT1 phosphorylation state. In contrast,
expression of Mt-SIRT1 caused only am o d e s td e c r e a s ei na c e t y l a t e d
H3 (Ac-H3) demonstrating substrate specificity for this response (Fig
6B). In addition, treatment of cells with H2O2 resulted in a significant
decrease in Ac-H3 and this effect was blocked by addition of JNKi
(Fig. 6B). Similarly, JNKi reduced the ability of over-expressed WT-
SIRT1 to deacetylate H3. Treatment with H2O2 did not decrease Ac-
H3 levels in cells expressing the Mt-SIRT1 (Fig. 6B) demonstrating
H2O2-mediated deacetylation of histone H3 is dependent on
phosphorylation of SIRT1. On the contrary, treatment with H2O2
increased acetylated p53 (Ac-p53) levels even in cells over-expressing
SIRT1 (either WT- or Mt-SIRT1) (Fig. 6C). Similar results were
obtained when cells were treated with anisomycin as shown in Figure
6D and E. These results demonstrate substrate specificity for the
ability of JNK1 to modulate SIRT1-mediated deacetylation.
Discussion
In this paper we describe a novel mechanism whereby oxidative
stress, via JNK1, regulates SIRT1 activity by altering its
subcellular localization and activity. First, we demonstrated that
SIRT1 and JNK1 functionally interact, but only when JNK1 is
activated by anisomycin or H2O2. Second, we showed that SIRT1
localization changes after treatment with H2O2, an effect blocked
by treatment of cells with a JNK1 inhibitor. Third, we confirmed
JNK1 as a kinase involved in phosphorylating SIRT1 at previously
identified sites (Ser27 and Ser47), and identified a novel JNK1
phosphorylation site (Thr530) on SIRT1. Fourth, we demonstrat-
ed a functional role of JNK1 phosphorylation of SIRT1, selective
deacetylation of histone H3 but not another SIRT1 substrate,
namely p53. Mutations of these sites into alanines abolished
JNK1-mediated phosphorylation of SIRT1 and abrogated the
functional changes seen with respect to histone H3. Finally, we
determined that the SIRT1:JNK1 interaction did not lead to a
change in JNK1 activity, as measured by levels of phosphorylated
cJun.
The findings presented here provide a molecular mechanism for
activation of SIRT1 in response to oxidative stress. This is the first
report identifying JNK1 as a kinase that functionally modifies
SIRT1, increasing SIRT1 activity and altering SIRT1 localiza-
tion. Specifically, phosphorylation of SIRT1 increases deacetyla-
tion of histone H3. By modifying chromatin SIRT1 induction
might modulate a set of genes that will confer protection from
oxidative stress. In support of this hypothesis, Berthiaume and
colleagues [14] have shown that high levels of cellular oxidative
stress globally inhibit gene transcription and this correlates with a
significant decrease in histone H3 and H4 acetylation. This could
be a protective mechanism to promote cell survival. Cells may
Figure 2. JNK1 regulates cellular localization of SIRT1. Immunohistochemistry of SIRT1 and JNK1. Cells were treated with control (A), H2O2 (B),
JNKi (C)o rH 2O2 plus JNKi (D). Cellular localization of JNK1 was determined by anti-rabbit JNK antibody and SIRT1 by anti-mouse SIRT1 antibody. Cells
were stained with DAPI stain to visualize nuclei. Arrows show SIRT1 localization.
doi:10.1371/journal.pone.0008414.g002
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DNA damage mediated by free radicals. Further studies to identify
changes in specific genes related to deacetylation of histone H3 are
ongoing. The findings presented here have implications in
understanding how SIRT1 might mediate the survival of cells
under oxidative stress conditions.
Recently, it has been shown that JNK2 can phopshorylate
SIRT1 at Ser27 under basal conditions, increasing SIRT1 protein
stability [15]. We can not rule the possibility that JNK2 may play a
role in H2O2 mediated phosphorylation of SIRT1. In addition,
cyclin dependent kinases (Cyclin B/Cdk1) phosphorylate SIRT1,
increasing deacetylase activity and regulating cell cycle progression
[16]. These studies suggest hierarchical levels of phosphorylation
as a second-site on SIRT1 must be phosphorylated to detect
Cyclin B/Cdk1 regulation. These findings, coupled with the work
presented here shed new light on how SIRT1 can be modified in
cells by postranslational modifications and in particular how
SIRT1 can differentially respond to physiological events, like
oxidative stress.
SIRT1 is a cell survival factor that may increase resistance to
oxidative stress in mammalian cells. In normal human fibroblast
IMR-90 cells, H2O2-induced apoptosis was attenuated by SIRT1
overexpression [17]. In HEK293T cells treated with serum
collected from calorie-restricted rats, SIRT1 expression level was
increased and Bax-mediated apoptosis was inhibited [18]. More
recently, it was shown that SIRT1 plays an essential role in
mediating cell survival in cardiac myocytes [19,20]. Kume et al [8]
have shown that H2O2-induction of p53 acetylation was decreased
in mesangial cells overexpressing SIRT1, similar to data we
obtained in a different cell line (HEK293T). In addition, neither
overexpression nor knockdown of SIRT1 affected H2O2-mediated
phosphorylation of MAP kinases (p38, JNK or MAPK). This is in
agreement with our finding that SIRT1 has no effect on JNK1
activity. Tanno et al [20] indicate that SIRT1 nucleocytoplasmic
shuttling, in response to oxidative stress, is a regulatory mechanism
which may increase cellular resistance to apoptosis. In keeping
with this notion, our data suggest that phosphorylation via JNK1 is
an important regulator of SIRT1 subcellular localization and
function. Taken together, these studies support the notion that
phosphorylation of SIRT1 by JNK1 is a protective mechanism
against oxidative stress.
The cellular balance between SIRT1 and poly(ADP-ribose)
polymerase-1 (PARP-1) activity may determine the effects of
oxidative stress on cell survival. In contrast to the present study,
activation of JNK1 (via oxidative stress) has previously been shown
to mediate cell death via PARP-1 activation [21]. PARP-1 is a
member of a nuclear enzyme family that functions as post-
translational regulators of DNA damage repair. Despite its
beneficial effect in DNA repair, PARP-1 activation has been
implicated in necrotic cell death. This apparent contrast in the
Figure 3. SIRT1 does not regulate JNK1 phosphorylation or activity. A, Inhibition of SIRT1 activity by nicotinamide or Sirtinol does not affect
phosphorylation of JNK1 in response to anisomycin. B, Inhibition of SIRT1 activity by nicotinamide or Sirtinol does not affect activity of JNK1 in
response to anisomycin. JNK1 activity was measured by its ability to phosphorylate c-Jun. C, Knockdown of SIRT1 by siRNA does not affect
anisomycin-mediated phosphorylation of JNK1. D, Knockdown of SIRT1 does not affect anisomycin-stimulated activity of JNK1. Clear bars are control.
Black bars are SIRT1 knockdown.
doi:10.1371/journal.pone.0008414.g003
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level of cellular damage. In the present study cells were treated
with H2O2 for 1 h, resulting in minimal cell death, whereas the
JNK1:PARP-1 association required longer (,6 h) cellular H2O2
exposure. Perhaps during prolonged H2O2 exposure, DNA
damage accumulates and massive PARP-1 activation quickly
depletes cellular NAD
+ (a SIRT1 co-substrate), leading to
decreased SIRT1 activity and necrotic cell death. Conversely,
acute (or low-level) exposure to oxidative stress activates SIRT1,
promoting the chance for cellular recovery.
During the last two decades progress in the genetics of aging in
invertebrate models such as C. elegans and D. melanogaster has clearly
demonstrated the existence of regulatory pathways that control the
rate of aging in these organisms, such as the insulin-like pathway,
the JNK pathway and the Sir2 deacetylase pathway [22]. It has
been shown both in Drosophila and in C.elegans that activation of the
stress responsive JNK pathway has major implications for
modulating lifespan. In both organisms it seems that the effect of
overexpression of JNK on increased lifespan was mediated by
nuclear localization of dFoxo/Daf16 and induction of its target
genes [23,24]. Here we show that in mammalian systems an
additional pathway might be responsible to protect cells under
oxidative stress conditions. It is not surprising that both
overexpression of SIRT1 and/or activation of the JNK pathway
lead to accumulation of less oxidative damage and increase
lifespan. The survival-enhancing characteristics of sirtuins suggest
that they influence mammalian responses to toxicity and could be
new therapeutic targets for improvement of tissue survival in
toxicity-related diseases, particularly neurodegenerative disorders.
In conclusion, oxidative stress activates JNK1, which directly
phosphorylates SIRT1 at Ser27, Ser47, and Thr530, concentrat-
ing it into the nucleus. In the nucleus, phosphorylated SIRT1
selectively deacetylates histone H3, but not p53. These findings
establish a molecular mechanism linking oxidative stress to SIRT1.
Materials and Methods
Cell Culture
Human embryonic kidney (293T) and mouse myoblast (C2C12)
cells from ATCC were cultured in Dulbecco’s modified Eagle
medium (DMEM). The media was supplemented with 10% fetal
bovine serum (FBS) and 10 mM HEPES. The day before
transfection, 293T cells at 3610
5 density were plated onto a
10 cm dish. For overexpression of SIRT1, 10 mg of wild-type and
Figure 4. SIRT1 is phosphorylated by JNK1. A, Schematic representation of full length human SIRT1 (FL hSIRT1) protein and a truncated form (aa
170–701 hSIRT1). Triangles show putative JNK1 phosphorylation sites. B, phosphorylation of SIRT1 by recombinant JNK1. FL hSIRT1 or a.a. 170–701
hSIRT1 was incubated with recombinant JNK1 or GSK3b in the presence of c-[
32P]-ATP. C, Schematic representation of mouse SIRT1 GST fragments.
Triangle represents the putative JNK phosphorylation site. D, In vitro phosphorylation of mouse SIRT1 GST when treated with JNK1
immunoprecipitates from anisomycin-treated C2C12 cells or recombinant JNK1. Truncated hSIRT1 (a.a. 170–701 hSIRT1) was used as positive control.
doi:10.1371/journal.pone.0008414.g004
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at 72 hours post-transfection. For knockdown (KD) of SIRT1,
SiRNAs targeting the SIRT1 and control siRNA were used at
20 nM concentration.
SIRT1 Plasmid Construction
The SIRT1 phospho-mutant construct was subcloned into the
pCMV Tag 4A (Flag tag) vector from Stratagene. Ser27Ala,
Ser47Ala and Thr530Ala mutations were performed by using site-
directed mutagenesis. The Ser27Ala mutagenesis was performed
by using the Advantage-GC 2 polymerase kit. The GC-melt
concentration was used from 0–1.5 M as recommended. PCR was
performed at 94uC for 3 min, then 30 cycles of 94uC for 30 sec
and 68uC for 6 min and one additional 68uC incubation for
6 min. A DpnI restriction digest was used to eliminate parental
DNA stands and the mixture was transformed using Stratagene
XL1-Blue Supercompetent cells. In addition a PstI silent
restriction site was incorporated into the mutant primers for
candidate screening. The Ser47Ala, Thr530Ala and stop mutation
sites were mutated by using the QuikChange II XL Site-Directed
Mutagenesis Kit. All mutations were sequence verified and
primers are listed in Table S1. Base pairs in bold represent the
mutated sites.
Treatments
To activate JNK1 activity, cells were treated with 500 mM
(13.3 M stock supplied) H2O2 for 30 min or with 10 mg per ml
(10 mg ml
21 stock in distilled water) anisomycin for 30 min at
37uC. To block the JNK1 kinase activation, cells were treated with
1 mM cell-permeable JNK inhibitor 1, (EMD Chemicals, Inc.,
Gibbstown, NJ, USA) overnight at 37uC before being exposed to
anisomycin for 30 min. Cells were treated with 10 mM nicotin-
Figure 5. Phosphorylation of hSIRT1. A and B, These peptide MSMS fragmentation spectra were obtained from the ex vivo FL hSIRT1 IP samples
after SDS PAGE and in-gel digestion. The spectrum in A shows phosphorylation of pS27 with neutral loss of 98 Da from the y8*, y9* and y10* ions
(indicated with a *). Spectrum B shows phosphorylation of pS47 with neutral loss of 98 Da from the b3* and b4* ions, but no neutral loss from the y
ions. C, The MSMS spectrum shown here was derived from in vitro experiments with hSIRT1 (a.a. 170–701) and shows phosphorylation of pT530 with
neutral loss of 98 Da for y14* to y17*. These spectra were produced from Mascot database searches with high confidence scores using data
generated from a nanoLC LTQ FT mass spectrometer.
doi:10.1371/journal.pone.0008414.g005
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(50 mM stock in DMSO) overnight before treatment with H2O2
or anisomycin. Controls for the experiments were treated with
distilled water and/or DMSO. For detection of acetylated Histone
3 (H3), the cells were incubated overnight with Trichostatin A
(TSA) at 400 nM concentration.
Antibodies
The rabbit anti-SIR2 polyclonal antibody was purchased from
Millipore (Billerica, MA, USA). Rabbit anti JNK antibody, rabbit
anti-phospho JNK pAb were purchased from Cell Signaling
Technology (Danvers, MA, USA). For immunofluorescence, anti-
mouse JNK1 mAb was purchased from BD Bioscience (San Jose,
CA, USA). Rabbit anti-Histone H3, Acetylated (1–20), pAb was
purchased from EMD Chemicals, Inc. Rabbit anti-Histone H3
pAb was purchased from Cell Signaling Technology.
Western Blotting and Co-Immunoprecipitation
For Western blot analysis, cells were lysed in RIPA lysis buffer
supplemented with 10 mM NaF, 2 mM Na3VO4, 1 mM PMSF,
5 mM pepstatin, 1 mM DTT, 10 U/ml aprotinin, 0.5 mM Na-
Pyrophosphate and 1 complete mini protease inhibitor cocktail
tablet per 10 ml. The lysate was incubated on ice for 30 min
followed by centrifugation at 14,000 rpm for 20 min at 4uC. The
protein concentration was determined using the Coomassie plus
protein assay reagent. Fifty mg lysates were denatured by adding
SDS loading buffer and heated at 99uC for 10 min. The
denatured samples were size fractionated by 4–12% SDS-PAGE
Figure 6. Mutation of putative JNK phosphorylation sites on hSIRT1 reduces phosphorylation and activity of SIRT1. A, In vitro
phosphorylation of full length (FL) hSIRT1 or SIRT1 with the putative JNK phosphorylation sites mutated (Mt-SIRT1). FL hSIRT1 or Mt-SIRT1 was
incubated with recombinant JNK1. B, Mt-SIRT1 shows decreased activity in deacetylation of histone H3. Cells were transfected with the empty vector
(CMV), WT hSIRT1 (WT) or Mt-SIRT1 (Mt) then treated with H2O2 or H2O2 plus JNK inhibitor (JNKi). SIRT1, acetylated histone H3 (Ac-H3) or total histone
H3 were examined by Western blotting. C, Mt-SIRT1 shows similar activity to WT SIRT1 in deacetylation of p53. Experiment performed as in B, except
that acetylated p53 (Ac-p53) and total p53 levels were monitored. The ratio Ac/Total shows the quantification of the expression levels of the
acetylated substrates vs. the total levels of the same substrates. D, Mt-SIRT1 shows decreased activity in deacetylation of histone3 (H3). Cells were
transfected with the empty vector (CMV), WT hSIRT1 (WT) or Mt-SIRT1 (Mt) then treated with anisomycin or anisomycin plus JNK inhibitor (JNKi).
SIRT1, acetylated histone H3 or total H3 were examined by Western blotting. E, Mt-SIRT1 shows similar activity to WT SIRT1 in deacetylation of p53
when cells were treated with anisomycin. The experiment was performed as in D, and the levels of acetylated p53 (Ac-p53) and total p53 were
determined by Western blotting.
doi:10.1371/journal.pone.0008414.g006
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antibodies (listed below) at 1:1000 dilutions were used overnight
at 4uC on a platform shaker. After incubation for 1 h with the
secondary antibody (donkey anti-rabbit HRP conjugated, 1:5000
or sheep anti-mouse HRP conjugated), the signals were detected
by ECL enhanced chemiluminescence reagent using Fujifilm
scanner.
For co-immunoprecipitation assays, protein A-Sepharose beads
were equilibrated with RIPA buffer and pre-coated with BSA
(0.5% for 1 hour). Immunoprecipitation assays were then
performed using 500 to 1,200 mg of total protein. Lysates were
pre-cleared by the addition of 30 ml of 50% slurry of pre-coated
protein A-sepharose beads per 500 mg of protein, by rocking at
4uC for 1 h. The supernatant was collected by centrifugation and
the SIRT1 protein was immunoprecipitated with rabbit anti-
mouse SIR2a polyclonal antibody (5 ml per 1000 mg of protein)
from Upstate (Millipore, Billerica MA, USA) by rocking overnight
at 4uC. Fifty to 100 ml of 50% slurry (pre-coated protein A
Sepharose beads) were added to the mixture and incubated for 2 h
at 4uC with rocking. The beads were washed three times with
RIPA buffer containing protease and phosphatase inhibitors. The
immunoprecipitates were eluted by boiling for 5 min in SDS
sample buffer and subjected to SDS-PAGE analysis and Western
blotting as described above with SIRT1 and JNK1 antibodies.
Immunofluorescence
C2C12 cells were cultured as described above. The cells were
plated on a Mat-Tek 35 mm glass bottom dish for H2O2 and/or
JNK inhibitor treatment. After treatment, the cells were washed
twice in PBS and fixed in 4% (in distilled water) para-
formaldehyde fixative for 30 min; they were then washed and
permeabilized three times (10 min each time) with 0.5% Triton-X-
100 in PBS. For immunostaining on fixed cells, the dishes were
rinsed with PBS containing 0.05% Tween-20 (PBST) and
incubated in blocking reagent (1% BSA, 20% horse serum) for
1 h at room temperature. The next stage involved overnight
incubation at 4uC in a 1:50 dilution of rabbit anti-SIR2 and mouse
anti-JNK1 antibodies followed by three washes with PBST before
incubation in Alexa-488-conjugated goat anti-rabbit or donkey
anti-mouse antibody at a dilution of 1:2000 for 1 h in dark
conditions. The cells were then washed three times in PBST and
once in PBS before being exposed to 300 nM DAPI and examined
in a Zeiss LSM 510 laser-scanning confocal microscope.
JNK1 Activity
PathScan phospho-c-Jun (Ser63) and total c-Jun sandwich
ELISA kit were used for measuring indirect JNK1 activity. Cell
extracts from control and SIRT1 knockdown were used for
measuring phosphorylation of c-Jun kinase. The ratio of phospho
c-JUN over total c-JUN was used to measure the level of
activation.
SIRT1 Recombinant Protein Purification
For in vitro kinase studies, recombinant full-length human
SIRT1 (FL hSIRT1) was purchased from Biomol International,
LP (Plymouth Meeting, PA). Truncated SIRT1 (amino acids 170–
701) was obtained by subcloning poly-histidine, S-tagged SIRT1
into a pNAT40 vector containing a PreScission protease cleavage
site after the S-tag. The resulting construct was transformed into
BL21DE3 cells, which were grown to an A600 of 0.6–0.8 prior to
induction with isopropyl-b-D-thiogalactopyranoside (IPTG) for
6 h. Cells were harvested and stored at 280uC until used. The
histidine, S-tagged SIRT1 protein was isolated using affinity,
anion exchange, and size exclusion chromatography. Briefly, cells
were lysed (using a French pressure cell) in lysis buffer containing
50 mM Tris pH 8, 300 mM NaCl, 2 mM TCEP, and Complete
protease inhibitor cocktail tablets (Roche Applied Science,
Indianapolis, IN). Cell debris was removed by centrifugation
(29,000 xg, 1 h, 4uC). The supernatant was loaded onto a nickel
column (HisPrep FF 16/10, GE Healthcare, Piscataway, NJ),
washed with lysis buffer, and eluted using an imidazole gradient
(0–500 mM). SIRT1 fractions were pooled and subject to
PreScission protease (GE Healthcare) treatment per manufactur-
er’s instructions to remove affinity tag. The cleaved product was
dialyzed against lysis buffer containing 50 mM NaCl, loaded onto
a mono Q column (10/100 GL, GE Healthcare) and eluted using
a NaCl gradient (50–1000 mM). SIRT1 fractions were pooled,
loaded onto a Superdex-200 column, and eluted in 50 mM Tris
pH 8, 500 mM NaCl, 2 mM TCEP, and 5% glycerol. SIRT1
fractions were pooled at stored at 280uC until used. The mouse
GST-SIRT1 fusion proteins were obtained from Department of
Diabetes, Mass General Hospital, Massachusetts under MTA
contract (Maria Alexander Bridges).
In vitro kinase assay-Equal amounts (1 mg) of the FL SIRT1 and
GST-SIRT1 fusion proteins were incubated with the activated
kinase (10 U) in kinase-specific reaction buffer containing 10 mCi
(0.37 MBq) Easytide c-33P–adenosine triphosphate (NEG602H).
The kinases used for these assays were JNK1 and GSK3b kinase.
The kinase reactions were incubated in kinase buffer at 30uC for
30 minutes and then stopped by the addition of Laemmli sample
buffer. The reactions were boiled and separated by SDS-PAGE.
The gels were dried and protein was detected by autoradiography.
For detecting the phosphorylation status of wild-type and mutant
SIRT1 proteins, both wild-type and mutant constructs were
overexpressed in 293T cells along with their control plasmid. The
equal amount of overexpressed proteins was immunoprecipitated
using rabbit anti SIR2 and sepharose Protein A beads. The pulled
down proteins were washed 3x times with kinase buffer. After
washing, the proteins bound to beads, were resuspended with
20 ml kinase buffer and kinased with recombinant JNK1.
Mass Spectrometry
In a typical experiment, endogenous SIRT1 was immunopre-
cipitated from 293T cells using the rabbit anti-SIR2 antibody. The
complex was run on a SDS denaturing gel. After CBB staining and
destaining the gel, gel bands were excised, washed using water/
acetonitrile (1/1) with 25 mM ammonium bicarbonate and
vortexing for 20 minutes. After dehydrating the bands, the
proteins therein were reduced using 10 mM DTT for 45 minutes
at 58uC. Next the proteins were alkylated on the cysteines using
iodoacetamide at room temperature, in the dark. The gel pieces
were then dried and rehydrated using the tryptic, chymotryptic or
GluC enzyme solution (1/50, enzyme/protein) in 50 mM
ammonium bicarbonate. Solution based samples, such as those
from the in vitro studies, were prepared in similar fashion, but with
no need to extract peptides from the gel matrix. The samples were
digested overnight at 37uC for trypsin and room temperature for
chymotrypsin and GluC. Peptides from the in-gel digests were
extracted using 50% acetonitrile, 45% water and 5% formic acid
with vortexing. After proteolysis peptides were dried down and
rehydrated in a small volume for loading to the liquid
chromatography mass spectrometry (LC/MS) instrument. Liquid
chromatography tandem mass spectrometry (LC/MS/MS) was
performed using a nano-flow RP HPLC (LC Packings Nanomate,
Dionex) flowing at 250 nL/min through a 10 cm675 mM
capillary column (Picotip, New Objective) using silica based C18
particles (3 mM diameter and 100 angstrom pore size, Magic C18,
Michrom Bioresources, Inc.). The gradient was over 55 minutes
JNK1 Phosphorylates SIRT1
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of eluting peptides was achieved using either a Q-Tof Global
(Micromass Q-Tof Global Ultima, Waters) or LTQ FT (Thermo)
set to acquire in data dependent mode. Processed data was
analyzed using Mascot (Matrix Sciences) to identify the proteins
from the gel bands and sites of phosphorylation on detected
peptides. The reference databases used were the human/mouse/
rat RefSeq protein database as well as a small custom protein
database.
Supporting Information
Table S1 The primers used to create the mutant SIRT1 are
described in this table.
Found at: doi:10.1371/journal.pone.0008414.s001 (0.03 MB
DOC)
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